Volumetric assessment of polycystic kidneys using computerized planimetry: analysis of accuracy and clinical significance
- Autores: Trushkin R.N.1, Medvedev P.E.1, Fettser D.V.1
-
Afiliações:
- Moscow Clinical Research Center Hospital No. 52, Moscow Healthcare Department
- Edição: Volume 17, Nº 3 (2025)
- Páginas: 62-66
- Seção: Nephrourology
- URL: https://journals.eco-vector.com/2075-3594/article/view/692777
- DOI: https://doi.org/10.18565/nephrology.2025.3.62-66
- ID: 692777
Citar
Texto integral



Resumo
Background. Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disorder characterized by the progressive growth of multiple cysts in both kidneys. An increase in total kidney volume (TKV), reflecting the growth of both cysts and (to a lesser extent) noncystic parenchyma, is a key biomarker of disease progression. Accurate assessment of TKV is critical for: 1. Early prediction of the rate of decline in renal function. 2. Patient selection for clinical trials of new drugs. 3. Assessing the effectiveness of specific therapy aimed at slowing cyst growth (e.g., tolvaptan). 4. Assessing the effectiveness of transarterial embolization as part of pretransplant preparation in patients undergoing nephrectomy. Magnetic resonance imaging (MRI) is often used to measure TKV, but computed tomography (CT) remains a widely available and frequently performed imaging modality in patients with ARPKD (e.g., for evaluation of hematuria, urolithiasis, or suspected tumor). Manual planimetry on CT images has historically been considered the “gold standard” for measuring the volume of complex structures, such as polycystic kidneys. However, this method is time-consuming and labor-intensive.
Objective. Evaluation of the accuracy, reproducibility, and clinical utility of computerized planimetry for measuring TKV in ARPKD.
Materials and methods. This prospective study included 20 patients with ARPKD and ESRD (40 kidneys) who underwent multislice computed tomography of the kidneys and retroperitoneal organs. The volume of each kidney was measured using manual planimetry on a workstation (a Toshiba Aquilion Prime 160-slice volumetric CT system (Japan) and an Agfa digital system). Measurements were performed by two independent radiologists to assess interoperator agreement. To assess intraoperator agreement, one radiologist performed measurements twice, 2 weeks apart. The volumes obtained by planimetry were compared with those calculated using the ellipsoid formula (Length × Width × Thickness × π/6).
Results. The mean kidney volume by planimetry was 5208.9 ± 452 ml (range: 1065–17926 ml). Ellipsoid-based volume estimates systematically underestimated true volume (mean difference 7.14%, p < 0.001), especially in patients with severe cystic kidney deformation. Inter- and intra-observer agreement (ICC = 0.987) and inter-observer agreement (ICC = 0.994) were exceptionally high.
Conclusion. Computerized planimetry is a highly accurate and reproducible method for estimating the volume of polycystic kidneys, significantly outperforming ellipsoid-based estimates. This method provides an objective and reliable quantitative measure of total renal parenchyma and cyst volume, which is important for monitoring ARPKD progression, assessing response to therapy (e.g., tolvaptan), and predicting renal function, as well as for evaluating the efficacy of transarterial embolization to assess volume reduction in polycystic kidneys.
Texto integral

Sobre autores
Ruslan Trushkin
Moscow Clinical Research Center Hospital No. 52, Moscow Healthcare Department
Autor responsável pela correspondência
Email: uro52@mail.ru
ORCID ID: 0000-0002-3108-0539
DR.Sci. (Med.), Professor, Department of Urology and Operative Nephrology with a Course in Oncourology, RUDN University, Head of the Urology Department
Rússia, MoscowPavel Medvedev
Moscow Clinical Research Center Hospital No. 52, Moscow Healthcare Department
Email: pah95@mail.ru
ORCID ID: 0000-0003-4250-0815
Cand.Sci. (Med.), Urologist, Department of Urology
Rússia, MoscowDenis Fettser
Moscow Clinical Research Center Hospital No. 52, Moscow Healthcare Department
Email: fettser@gmail.com
ORCID ID: 0000-0002-4143-8899
Cand.Sci. (Med.), X-ray Endovascular Surgeon, Head of the Department of X-ray Surgical Diagnostic and Treatment Methods
Rússia, MoscowBibliografia
- Demoulin N, Nicola V, Michoux N, Gillion V, Ho TA, Clerckx C, Pirson Y, Annet L. Limited Performance of Estimated Total Kidney Volume for Follow-up of ADPKD. Kidney Int Rep. 2021 Aug 19;6(11):2821-2829. doi: 10.1016/j.ekir.2021.08.013. PMID: 34805634; PMCID: PMC8589695.
- Bevilacqua M, Hague CJ, Romann A, Levin A. Accuracy, Reproducibility and User Experience With Standardized Instructions for Measurement of Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease. Can Assoc Radiol J. 2023 May;74(2):343-350. doi: 10.1177/08465371221124120. Epub 2022 Sep 5. PMID: 36063401.
- Kline TL, Korfiatis P, Edwards ME, Warner JD, Irazabal MV, King BF, Torres VE, Erickson BJ. Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression. Nephrol Dial Transplant. 2016 Feb;31(2):241-8. doi: 10.1093/ndt/gfv314. Epub 2015 Aug 31. PMID: 26330562; PMCID: PMC4725388.
- Bevilacqua MU, Hague CJ, Romann A, Sheitt H, Vasilescu DM, Yi TW, Levin A. CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose. Radiology. 2019 Jun;291(3):660-667. doi: 10.1148/radiol.2019181830. Epub 2019 Apr 9. PMID: 30964424.
- Edwards ME, Blais JD, Czerwiec FS, Erickson BJ, Torres VE, Kline TL. Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease. Clin Kidney J. 2019 Feb;12(1):71-77. doi: 10.1093/ckj/sfy078. Epub 2018 Aug 29. PMID: 30746130; PMCID: PMC6366146.
- Sharma K, Caroli A, Quach LV, Petzold K, Bozzetto M, Serra AL, Remuzzi G, Remuzzi A. Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease. PLoS One. 2017 May 30;12(5): e0178488. doi: 10.1371/journal.pone.0178488. PMID: 28558028; PMCID: PMC5448775.
- Kline TL, Korfiatis P, Edwards ME, Blais JD, Czerwiec FS, Harris PC, King BF, Torres VE, Erickson BJ. Performance of an Artificial Multi-observer Deep Neural Network for Fully Automated Segmentation of Polycystic Kidneys. J Digit Imaging. 2017 Aug;30(4):442-448. doi: 10.1007/s10278-017-9978-1. PMID: 28550374; PMCID: PMC5537093.
- van Gastel MDA, Edwards ME, Torres VE, Erickson BJ, Gansevoort RT, Kline TL. Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2019 Aug;30(8):1514-1522. doi: 10.1681/ASN.2018090902. Epub 2019 Jul 3. PMID: 31270136; PMCID: PMC6683702.
- Kim Y, Tao C, Kim H, Oh GY, Ko J, Bae KT. A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2022 Aug;33(8):1581-1589. doi: 10.1681/ASN.2021111400. Epub 2022 Jun 29. PMID: 35768178; PMCID: PMC9342631.
- Sore R, Cathier P, Vlachomitrou AS, Bailleux J, Arnaud K, Juillard L, Lemoine S, Rouvière O. Deep learning-based segmentation of kidneys and renal cysts on T2-weighted MRI from patients with autosomal dominant polycystic kidney disease. Eur Radiol Exp. 2024 Oct 30;8(1):122. doi: 10.1186/s41747-024-00520-7. PMID: 39477840; PMCID: PMC11525362.
- Sekine A, Hidaka S, Moriyama T, Shikida Y, Shimazu K, Ishikawa E, Uchiyama K, Kataoka H, Kawano H, Kurashige M, Sato M, Suwabe T, Nakatani S, Otsuka T, Kai H, Katayama K, Makabe S, Manabe S, Shimabukuro W, Nakanishi K, Nishio S, Hattanda F, Hanaoka K, Miura K, Hayashi H, Hoshino J, Tsuchiya K, Mochizuki T, Horie S, Narita I, Muto S. Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD). J Clin Med. 2022 Nov 3;11(21):6528. doi: 10.3390/jcm11216528. PMID: 36362756; PMCID: PMC9657046.
Arquivos suplementares
